The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects
- 1 January 1995
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 117 (2) , 186-192
- https://doi.org/10.1007/bf02245186
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Proposed supplements and amendments to ‘A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects’, the Rechtschaffen & Kales (1968) standardPsychiatry and Clinical Neurosciences, 2001
- Effects of ipsapirone, a 5‐HT1Aagonist, on sleep/wakefulness cycles: probable post‐synaptic actionJournal of Sleep Research, 1993
- Axonal and somato‐dendritic modalities of serotonin release: their involvement in sleep preparation, triggering and maintenanceJournal of Sleep Research, 1992
- Brain metabolism and blood flow during sleepJournal of Sleep Research, 1992
- Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigmLife Sciences, 1991
- Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in ratsBehavioural Brain Research, 1990
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987
- Subtypes of 5-HT receptorsJournal of Psychopharmacology, 1987
- Sleep: a neurobiological window on affective disordersTrends in Neurosciences, 1985
- Physical Fitness, Exercise, and REM Sleep Cycle LengthPsychophysiology, 1982